PETS · Petmed Express Inc · Financials
The latest filing states the doubt was alleviated.
“During the three months ended June 30, 2026, management's assessment identified certain conditions and events that, when considered in the aggregate, raised substantial doubt about the Company's ability to continue as a going concern. ... Management determined that these plans are probable of being effectively implemented and are probable of mitigating the conditions that raised substantial doubt. As of the issuance of these financials, management has concluded that substantial doubt about the Company's ability to continue as a going concern for the next twelve months is alleviated by these plans.”View the 10-Q filed Aug 13, 2026
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Chart any reported metric, KPI or segment over time — the full statement history lives here
| Line Item | TTM | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| $168.86M | $179.02M | $226.97M | $274.1M | $247.57M | $272.28M | $303.58M | $284.13M | $283.42M | $273.8M | $249.18M | $234.68M | — | — | — | — | — | — | |
| — | — | $157.84M | $189.33M | $171.07M | $195.34M | $219.27M | $202.88M | $188.11M | $175.99M | $169.86M | $158.39M | $153.13M | $155.77M | $150.71M | $158.09M | $147.69M | $146.41M | |
| $47.15M | $50.22M | $69.14M | $84.77M | $76.5M | $76.94M | $84.32M | $81.25M | $95.31M | $97.81M | $79.31M | $76.3M | $76.27M | $77.62M | $77.12M | $80.17M | $83.96M | $91.86M | |
| — | 28.05% | 30.46% | 30.93% | 30.9% | 28.26% | 27.77% | 28.6% | 33.63% | 35.72% | 31.83% | 32.51% | — | — | — | — | — | — | |
| $48.98M | $50.73M | $38.65M | $55.25M | $41.71M | $31.11M | $29.72M | $25.26M | $24.77M | $24.29M | $22.8M | $21.3M | $21.1M | $21.35M | $21.59M | $22.36M | $22.2M | $22.34M | |
| $1.7M | $2M | $2M | $2M | $0 | — | — | — | — | — | — | — | — | — | — | — | — | — | |
| $9.25M | $9.39M | $7.04M | $7.06M | $3.55M | $2.74M | — | — | — | — | — | — | — | — | — | — | — | — | |
| $77.92M | $108.89M | $70.67M | $92.93M | $70.45M | $52.65M | $53.79M | $50.27M | $49.14M | $45.67M | $41.83M | $43.91M | $48.66M | $49.4M | $50.12M | $54.14M | $50.93M | $51.32M | |
| -$30.77M | -$58.67M | -$1.53M | -$8.16M | $6.05M | $24.29M | $30.53M | $30.98M | $46.17M | $52.14M | $37.48M | $32.39M | $27.61M | $28.22M | $27.01M | $26.02M | $33.02M | $40.54M | |
| — | -32.77% | -0.67% | -2.98% | 2.44% | 8.92% | 10.06% | 10.9% | 16.29% | 19.04% | 15.04% | 13.8% | — | — | — | — | — | — | |
| -$21.52M | -$49.29M | $5.51M | -$1.11M | $9.6M | $27.03M | — | — | — | — | — | — | — | — | — | — | — | — | |
| — | — | — | — | $2.07M | $335K | $314K | $1.75M | $1.86M | $658K | $141K | $190K | $184K | $185K | $306K | $288K | $381K | $196K | |
| $1.43M | $1.31M | $943K | $1.89M | $1.39M | -$105K | $419K | $2.92M | $2.95M | $1.65M | $441K | $179K | $185K | $181K | $301K | $349K | $253K | $200K | |
| -$29.35M | -$57.36M | -$587K | -$6.27M | $7.45M | $24.19M | $30.95M | $33.89M | $49.12M | $53.79M | $37.92M | $32.57M | $27.8M | $28.4M | $27.31M | $26.37M | $33.28M | $40.74M | |
| -$69K | -$73K | $5.68M | $1.19M | $2.31M | $5.47M | $7.03M | $8.04M | $11.38M | $16.51M | $14.11M | $12M | $10.35M | $10.43M | $10.14M | $9.71M | $12.41M | $14.74M | |
| -$29.28M | -$57.29M | -$6.27M | -$7.46M | $5.14M | $18.72M | $23.92M | $25.85M | $37.74M | $37.28M | $23.82M | $20.57M | $17.45M | $17.97M | $17.17M | $16.66M | $20.87M | $26M | |
| — | -32% | -2.76% | -2.72% | 2.08% | 6.87% | 7.88% | 9.1% | 13.32% | 13.62% | 9.56% | 8.76% | — | — | — | — | — | — | |
| $25.47M | — | — | — | — | — | — | — | $37.74M | $37.28M | $23.82M | $20.62M | $17.44M | $17.94M | $17.12M | $16.84M | $20.84M | — | |
| USD/shares | -$1.37 | -$2.74 | -$0.30 | -$0.37 | $0.25 | $0.93 | $1.19 | $1.29 | $1.84 | $1.83 | $1.18 | $1.02 | $0.87 | $0.90 | $0.86 | $0.81 | $0.93 | $1.15 |
| USD/shares | -$1.37 | -$2.74 | -$0.30 | -$0.37 | $0.25 | $0.92 | $1.19 | $1.29 | $1.84 | $1.82 | $1.17 | $1.02 | $0.87 | $0.90 | $0.86 | $0.80 | $0.92 | $1.14 |
| shares | — | 20.92M | 20.6M | 20.4M | 20.27M | 20.18M | 20.06M | 20.04M | 20.46M | 20.35M | 20.23M | 20.12M | 20.02M | 19.9K | 19.93M | 20.61M | 22.51M | 22.62M |
| shares | — | 20.92M | 20.6M | 20.4M | 20.34M | 20.36M | 20.12M | 20.06M | 20.49M | 20.43M | 20.38M | 20.25M | 20.14M | 20.04K | 20.05M | 20.71M | 22.64M | 22.75M |
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2010–FY2026: $51.29M in buybacks, $263.24M in dividends.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current operating lease liabilities | 2026-06-30 | USD 414,000 | 10-Q filed 2026-08-13 |
| Noncurrent operating lease liabilities | 2026-06-30 | USD 0 | 10-Q filed 2026-08-13 |
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.
Price & Valuation
Multiples computed on the strict TTM/EV methodology — today's snapshot against peers, and each ratio recomputed as of past filing dates.
Valuation
Valuation over time computed as of each quarter's filing date
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Segment (USD)
| Component | FY2026 | FY2025 | FY2024 | FY2023 |
|---|---|---|---|---|
| Reportable Segment | $179,021,000 | $226,972,000 | $274,095,000 | $247,569,000 |